← Organogenesis Holdings Inc. ORGO
Market Price
$1.79
Market Cap
$226.47M
P/E Ratio
11.93
Revenue (FY 2025)
↑17.0% YoY
$564.17M
3-Yr CAGR: 7.8%
Net Income
↑4,201.0% YoY
$37.03M
Net Margin: 6.6%
Free Cash Flow
↓-685.7% YoY
-$24.46M
FCF Yield: -10.80%
EPS (Diluted)
↑1,600.0% YoY
$0.15
Basic: $0.16
Return on Equity
Efficiency
12.3%
ROA: 201.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ORGO)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | — | — | $-48.2M | $-0.2M | — | $-0.03 | — | $-0.6M | $-1.9M | — |
| FY 2017 | — | — | $-61.2M | $-2.1M | -903.3% | $-0.48 | -1,500.0% | $-0.6M | $-3.0M | -56.6% |
| FY 2018 | $193.4M | — | $124.6M | $-64.8M | -2,996.2% | $-0.94 | -95.8% | $-60.7M | $-62.6M | -1,977.8% |
| FY 2019 | $261.0M | +34.9% | $185.0M | $-40.5M | +37.6% | $-0.44 | +53.2% | $-33.5M | $-39.5M | +36.9% |
| FY 2020 | $338.3M | +29.6% | $251.0M | $17.9M | +144.4% | $0.16 | +136.4% | $6.8M | $-14.3M | +63.7% |
| FY 2021 | $468.1M | +38.4% | $353.9M | $94.9M | +428.7% | $0.71 | +343.7% | $62.0M | $30.8M | +314.4% |
| FY 2022 | $450.9M | -3.7% | $345.9M | $15.5M | -83.6% | $0.12 | -83.1% | $24.9M | $-9.0M | -129.4% |
| FY 2023 | $433.1M | -3.9% | $326.7M | $4.9M | -68.2% | $0.04 | -66.7% | $30.9M | $6.6M | +172.5% |
| FY 2024 | $482.0M | +11.3% | $366.3M | $0.9M | -82.6% | $-0.01 | -125.0% | $14.2M | $4.2M | -36.3% |
| FY 2025 | $564.2M | +17.0% | $426.6M | $37.0M | +4,201.0% | $0.15 | +1,600.0% | $-10.3M | $-24.5M | -685.7% |
Valuation
Market Price
$1.79
Market Cap
$226.47M
Enterprise Value
N/A
P/E Ratio
11.93
P/B Ratio
0.77
FCF Yield
-10.80%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
75.62%
Operating Margin
7.92%
Net Margin
6.56%
Return on Equity (ROE)
12.34%
Return on Assets (ROA)
201.77%
Asset Turnover
30.74x
Revenue 3-Yr CAGR
7.76%
Financial Health & Liquidity
Current Ratio
0.37
Cash Ratio
1.89
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$93.68M
Total Debt
N/A
Book Value / Share
$2.33
Cash Flow Efficiency
Operating Cash Flow
-$10.31M
Capital Expenditures (CapEx)
$14.15M
Free Cash Flow
-$24.46M
OCF / Revenue
-1.83%
FCF / Revenue
-4.34%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.15
EPS (Basic)
$0.16
Dividends / Share
N/A
Book Value / Share
$2.33
EPS YoY Growth
1,600.00%
Balance Sheet (FY 2025)
Total Assets
$18.35M
Total Liabilities
$49.53M
Stockholders' Equity
$300.13M
Current Assets
$18.35M
Current Liabilities
$49.53M